Stock Information
Agios Pharmaceuticals Inc (AGIO)
Ticker Symbol: AGIO
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,052.65 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -7.1183
Revenue (TTM): $0.93 M
Dividend Yield: N/A%
ROE: -31.07%
Latest News
-
AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD
Wed, Apr 1, 2026 3:12 PM
-
Goldman Sachs Maintains Neutral on Agios Pharmaceuticals, Raises Price Target to $32
Wed, Apr 1, 2026 1:35 PM
-
A Look At Agios Pharmaceuticals (AGIO) Valuation After Recent Share Price Momentum
Wed, Apr 1, 2026 11:20 AM
-
Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?
Wed, Apr 1, 2026 9:47 AM
-
Agios Rallies On A Surprise FDA Move In Sickle Cell, Pulling Rival Fulcrum Higher
Tue, Mar 31, 2026 8:02 PM
-
Sector Update: Health Care Stocks Higher Late Afternoon
Tue, Mar 31, 2026 7:55 PM
-
Sector Update: Health Care Stocks Higher Tuesday Afternoon
Tue, Mar 31, 2026 5:42 PM
-
Why Agios Pharmaceuticals Stock Is Up More Than 21% Today
Tue, Mar 31, 2026 4:28 PM
-
Insider Sells AGIO Shares Worth $82,000 -- But Context Is Everything
Tue, Mar 31, 2026 4:23 PM
-
Why Is Agios Pharmaceuticals Stock Surging Tuesday Afternoon?
Tue, Mar 31, 2026 12:39 PM
Key Financials
Financial data not available
